| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alto Neuroscience, Inc. (ANRO) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. ANRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 188.0K | $4.31M | - | |
| CFO | 45.0K | $1.03M | - | |
| CEO | 34.6K | $792.8K | - | |
| Other | 22.5K | $514.8K | - | |
| Dir | 15.3K | $350.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | Chief Medical Officer | Buy | 15,000 | $12.72 | $190,832.95 | +15.4% | -10.6% | -79.5% | |
| Mar 28, 2024 | Smith Nicholas Conrad | Chief Financial Officer | Buy | 6,150 | $16.36 | $100,628.00 | +14.3% | -35.1% | -85.2% | |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Buy | 600,000 | $16.00 | $9,600,000.00 | +19.3% | -26.3% | -78.3% | |
| Feb 6, 2024 | Smith Nicholas Conrad | Chief Financial Officer | Buy | 1,563 | $16.00 | $25,008.00 | New | -26.3% | -78.3% | |
| Feb 6, 2024 | Savitz Adam | Chief Medical Officer | Buy | 17,000 | $16.00 | $272,000.00 | +216.5% | -26.3% | -78.3% | |
| Feb 6, 2024 | Etkin Amit | President And CEO | Buy | 3,125 | $16.00 | $50,000.00 | +0.3% | -26.3% | -78.3% |